Raffles Medical

Forecast & Rating6 analysts currently cover Raffles Medical, with about 50.0% giving a positive rating — meaning they expect the stock to rise. The average price target is S$1.05, about 24.3% upside from the current price of S$0.85. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 31.7% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Raffles Medical are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Sep 10, 2026; for reference only and not investment advice.